There is ample evidence to support the use of spinal cord stimulation in the treatment of refractory painful diabetic neuropathy.[1, 2] Adverse effects of spinal cord stimulator implant have been well documented and include the risks of lead migration, infection, spinal cord injury, intolerance, and others. However, there have been few reports of diabetic ketoacidosis following this intervention.
Nothing to Disclose by any Author
Associate Research Coordinator, Physician Assistant,
Western Reserve Hospital
Western Reserve Hospital - Center for Pain Medicine